IVA

$0.00

(

+0.00%

)
Quote details

stock

Inventiva Sa

NASDAQ | IVA

4.61

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 13, 2025)

$679.20M

Market Cap

-

P/E Ratio

-4.37

EPS

$6.55

52 Week High

$2.11

52 Week Low

HEALTHCARE

Sector

IVA Chart

Recent Chart
Price Action

IVA Technicals

Tags:

IVA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit $9.2M
Total Revenue $9.2M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$98M
Selling General And Administrative $15M
Research And Development $91M
Operating Expenses $107M
Investment Income Net -
Net Interest Income -$11M
Interest Income $1.1M
Interest Expense $12M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.2M
Income Before Tax -$184M
Income Tax Expense $313K
Interest And Debt Expense -
Net Income From Continuing Operations -$184M
Comprehensive Income Net Of Tax -
Ebit -$172M
Ebitda -$167M
Net Income -$184M

Revenue & Profitability

Earnings Performance

IVA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (EUR)
Total Assets $119M
Total Current Assets $112M
Cash And Cash Equivalents At Carrying Value $97M
Cash And Short Term Investments $97M
Inventory $0
Current Net Receivables $12M
Total Non Current Assets $7.5M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $48K
Intangible Assets Excluding Goodwill $48K
Goodwill -
Investments -
Long Term Investments $1.1M
Short Term Investments $0
Other Current Assets $2.8M
Other Non Current Assets -
Total Liabilities $226M
Total Current Liabilities $121M
Current Accounts Payable $33M
Deferred Revenue -
Current Debt -
Short Term Debt $5.9M
Total Non Current Liabilities $105M
Capital Lease Obligations $4.7M
Long Term Debt $46M
Current Long Term Debt $3.3M
Long Term Debt Noncurrent -
Short Long Term Debt Total $54M
Other Current Liabilities $78M
Other Non Current Liabilities $30M
Total Shareholder Equity -$107M
Treasury Stock -
Retained Earnings -$184M
Common Stock $957K
Common Stock Shares Outstanding $52M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (EUR)
Operating Cashflow -$86M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $5.2M
Capital Expenditures $333K
Change In Receivables -
Change In Inventory $417K
Profit Loss -
Cashflow From Investment $8.7M
Cashflow From Financing $146M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$184M

yearly Income Statement (As of Dec 31, 2024)

Field Value (EUR)
Gross Profit $9.2M
Total Revenue $9.2M
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$98M
Selling General And Administrative $15M
Research And Development $91M
Operating Expenses $107M
Investment Income Net -
Net Interest Income -$11M
Interest Income $1.1M
Interest Expense $12M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $5.2M
Income Before Tax -$184M
Income Tax Expense $313K
Interest And Debt Expense -
Net Income From Continuing Operations -$184M
Comprehensive Income Net Of Tax -
Ebit -$172M
Ebitda -$167M
Net Income -$184M

IVA News

IVA Profile

Inventiva Sa Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Inventiva SA (IVA) is a clinical-stage biopharmaceutical company headquartered in Daix, France, specializing in the discovery and development of innovative oral small molecule therapies targeting diseases with high unmet medical needs, including non-alcoholic steatohepatitis (NASH) and mucopolysaccharidosis (MPS). The company's robust pipeline is driven by a commitment to address complex metabolic and rare diseases through its proprietary drug candidates, positioning it as a key player in the evolving biopharmaceutical landscape. As Inventiva advances toward pivotal clinical trials, it holds the potential to significantly impact patient outcomes and capture value within the biotechnology sector.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
PFE
-0.30%
$24.70
RR
+7.85%
$6.38
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
XCH
+119.76%
$1.81
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
WWR
0.00%
$1.98
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
HOOD
+1.03%
$140.40
PMAX
+44.78%
$3.75
HPE
+2.76%
$25.07
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+149.66%
$10.38
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BITF
+25.47%
$5.26
IONZ
-35.04%
$2.21
BYND
-47.01%
$1.06
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
ETHD
-11.62%
$3.37
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
TLRY
+0.58%
$1.73
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
ONDS
+18.43%
$10.92
PFE
-0.30%
$24.70
RR
+7.85%
$6.38
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
XCH
+119.76%
$1.81
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
WWR
0.00%
$1.98
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
HOOD
+1.03%
$140.40
PMAX
+44.78%
$3.75
HPE
+2.76%
$25.07
TMC
+18.40%
$10.52
ABEV
+1.42%
$2.14

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.